Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.

Ibrahim T, Liverani C, Mercatali L, Sacanna E, Zanoni M, Fabbri F, Zoli W, Amadori D.

Int J Oncol. 2016 Sep;49(3):1260. doi: 10.3892/ijo.2016.3613. Epub 2016 Jul 6.

2.

CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.

Salvi S, Casadio V, Burgio SL, Conteduca V, Rossi L, Menna C, Carretta E, Costantini M, Zoli W, De Giorgi U.

Int J Biol Markers. 2016 Jul 30;31(3):e264-9. doi: 10.5301/jbm.5000197.

PMID:
26954071
3.

Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.

Salvi S, Gurioli G, Martignano F, Foca F, Gunelli R, Cicchetti G, De Giorgi U, Zoli W, Calistri D, Casadio V.

Dis Markers. 2015;2015:574120. doi: 10.1155/2015/574120. Epub 2015 Aug 27.

4.

eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.

Ulivi P, Scarpi E, Passardi A, Marisi G, Calistri D, Zoli W, Del Re M, Frassineti GL, Tassinari D, Tamberi S, Vertogen B, Amadori D.

J Transl Med. 2015 Aug 11;13:258. doi: 10.1186/s12967-015-0619-5.

5.

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.

Musuraca G, De Matteis S, Napolitano R, Papayannidis C, Guadagnuolo V, Fabbri F, Cangini D, Ceccolini M, Giannini MB, Lucchesi A, Ronconi S, Mariotti P, Savini P, Tani M, Fattori PP, Guidoboni M, Martinelli G, Zoli W, Amadori D, Carloni S.

J Transl Med. 2015 Jul 15;13:229. doi: 10.1186/s12967-015-0590-1.

6.

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

Bravaccini S, Tumedei MM, Ulivi P, Zoli W, Calistri D, Candoli P, Amadori D, Puccetti M.

Cytopathology. 2016 Apr;27(2):103-7. doi: 10.1111/cyt.12237. Epub 2015 Mar 10.

PMID:
25757141
7.

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab.

Chiadini E, Scarpi E, Passardi A, Calistri D, Valgiusti M, Saragoni L, Zoli W, Amadori D, Ulivi P.

Oncol Lett. 2015 Mar;9(3):1432-1438. Epub 2015 Jan 14.

8.

Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations.

Barriere G, Fici P, Gallerani G, Fabbri F, Zoli W, Rigaud M.

Ann Transl Med. 2014 Nov;2(11):109. doi: 10.3978/j.issn.2305-5839.2014.10.04. Review.

9.

Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer.

Pignatta S, Orienti I, Falconi M, Teti G, Arienti C, Medri L, Zanoni M, Carloni S, Zoli W, Amadori D, Tesei A.

Nanomedicine. 2015 Feb;11(2):263-73. doi: 10.1016/j.nano.2014.10.004. Epub 2014 Nov 18.

PMID:
25461293
10.

Improving reliability of live/dead cell counting through automated image mosaicing.

Piccinini F, Tesei A, Paganelli G, Zoli W, Bevilacqua A.

Comput Methods Programs Biomed. 2014 Dec;117(3):448-63. doi: 10.1016/j.cmpb.2014.09.004. Epub 2014 Sep 28.

PMID:
25438936
11.

New biomarkers to predict the evolution of in situ breast cancers.

Bravaccini S, Tumedei MM, Scarpi E, Zoli W, Rengucci C, Serra L, Curcio A, Buggi F, Folli S, Rocca A, Maltoni R, Puccetti M, Amadori D, Silvestrini R.

Biomed Res Int. 2014;2014:159765. doi: 10.1155/2014/159765. Epub 2014 Aug 26.

12.

Improved stool DNA integrity method for early colorectal cancer diagnosis.

Rengucci C, De Maio G, Menghi M, Scarpi E, Guglielmo S, Fusaroli P, Caletti G, Saragoni L, Casadei Gardini A, Zoli W, Falcini F, Amadori D, Calistri D.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2553-60. doi: 10.1158/1055-9965.EPI-14-0379. Epub 2014 Aug 15.

13.

Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples.

Capelli L, Marfisi C, Puccetti M, Saragoni L, De Paola F, Zaccaroni A, Chiadini E, Gagliardi L, Ferretti G, Zoli W, Ulivi P.

Cytopathology. 2015 Oct;26(5):297-302. doi: 10.1111/cyt.12199. Epub 2014 Aug 14.

PMID:
25123949
14.

Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence.

Rengucci C, De Maio G, Casadei Gardini A, Zucca M, Scarpi E, Zingaretti C, Foschi G, Tumedei MM, Molinari C, Saragoni L, Puccetti M, Amadori D, Zoli W, Calistri D.

J Exp Clin Cancer Res. 2014 Aug 5;33:65. doi: 10.1186/s13046-014-0065-x.

15.

Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissue.

Marisi G, Passardi A, Calistri D, Zoli W, Amadori D, Ulivi P.

Int J Mol Sci. 2014 Jul 30;15(8):13333-43. doi: 10.3390/ijms150813333.

16.

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy.

Cecconetto L, Casadei Gardini A, Tenti E, Maltoni R, Bravaccini S, Oboldi D, Zoli W, Serra P, Donati C, Sarti S, Amadori D, Rocca A.

Tumori. 2014 May-Jun;100(3):e79-82. doi: 10.1700/1578.17238.

PMID:
25076256
17.

Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer.

Salvi S, Calistri D, Gurioli G, Carretta E, Serra L, Gunelli R, Zoli W, Casadio V.

Int J Mol Sci. 2014 Jul 14;15(7):12458-68. doi: 10.3390/ijms150712458.

18.

First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer.

Tedaldi G, Danesi R, Zampiga V, Tebaldi M, Bedei L, Zoli W, Amadori D, Falcini F, Calistri D.

BMC Cancer. 2014 Jul 1;14:478. doi: 10.1186/1471-2407-14-478.

19.

CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.

Liverani C, Mercatali L, Spadazzi C, La Manna F, De Vita A, Riva N, Calpona S, Ricci M, Bongiovanni A, Gunelli E, Zanoni M, Fabbri F, Zoli W, Amadori D, Ibrahim T.

Bone. 2014 Sep;66:214-22. doi: 10.1016/j.bone.2014.06.017. Epub 2014 Jun 20.

PMID:
24956020
20.

miRNAs as non-invasive biomarkers for lung cancer diagnosis.

Ulivi P, Zoli W.

Molecules. 2014 Jun 17;19(6):8220-37. doi: 10.3390/molecules19068220. Review.

Supplemental Content

Support Center